Background: The COVID-19 pandemic has boosted the use of forced expiratory volume in 1 second (FEV1) telemonitoring in pediatric asthma, but a consensus on its most efficient and effective implementation is still lacking. To find answers, it is important to study how such an intervention is perceived, experienced, and used by both patients and health care professionals (HCPs). Objective: The aim of this study was to provide perspectives on how FEV1 home monitoring should be used in pediatric asthma. Methods: This is a qualitative, multicenter, prospective, observational study which included patients with asthma aged 6-16 and HCPs. Primary outcomes were results of 2 surveys that were sent to all participants at study start and after 3-4 months. Secondary outcomes consisted of FEV1 device usage during 4 months after receiving the FEV1 device. Results: A total of 39 participants (26 patients and 13 HCPs) were included in this study. Survey response rates were 97% (38/39) at the start and 87% (34/39) at the end of the study. Both patients and HCPs were receptive toward online FEV1 home monitoring and found it contributive to asthma control, self-management, and disease perception. The main concerns were about reliability of the FEV1 device and validity of home-performed lung function maneuvers. FEV1 devices were used with a median frequency of 7.5 (IQR 3.3-25.5) during the 4-month study period. Conclusions: Patients and HCPs are receptive toward online FEV1 home monitoring. Frequency of measurements varied largely among individuals, yet perceived benefits remained similar. This emphasizes that online FEV1 home monitoring strategies should be used as a means to reach individual goals, rather than being a goal on their own.
Introduction: There is need for real‐life, long‐term and large‐scale multicentre studies on remote monitoring (RM) in respiratory care to determine its true potential for daily practice. We aimed to analyze the effect of RM with digital action plans on healthcare utilization in long‐term pediatric asthma care. Methods: This was a cohort study in six Dutch pediatric asthma clinics from 2017 until 2023 using healthcare utilization and RM data. Children aged 6–18 years with ≥ 2 years follow‐up were included. Differences in median number of outpatient visits between the RM and regular care groups were assessed. Incidence rate ratios (IRR) were calculated for emergency visits and hospitalizations. Interrupted time series analysis was used to evaluate changes in number of outpatient visits after introduction of RM over time. Asthma control of children with RM was analyzed over time. Results: We included 2526 children, of which 1372 (54.2%) used RM. The median number of annual outpatient visits was lower in the RM group than in the regular care group (ΔMedian 0.65, p < 0.001). RM was associated with a decreased risk of emergency visits (IRR 0.52; 95% CI 0.44, 0.61) and hospitalizations (IRR 0.43; 95% CI 0.34, 0.55). RM was associated with an annual outpatient visit reduction of −9.4 (95% CI −17.0, −1.9) per 100 children. The proportion of children with controlled asthma increased from 76.7% to 86.0% 3 years after introduction of RM. Conclusions: RM with digital treatment plans is associated with reductions in both regular and emergency healthcare utilization while maintaining high rates of well‐controlled asthma.
BACKGROUND The COVID-19 pandemic has boosted the use of forced expiratory volume in 1 second (FEV1) telemonitoring in pediatric asthma, but a consensus on its most efficient and effective implementation is still lacking. To find answers, it is important to study how such an intervention is perceived, experienced, and used by both patients and health care professionals (HCPs). OBJECTIVE The aim of this study was to provide perspectives on how FEV1 home monitoring should be used in pediatric asthma. METHODS This is a qualitative, multicenter, prospective, observational study which included patients with asthma aged 6-16 and HCPs. Primary outcomes were results of 2 surveys that were sent to all participants at study start and after 3-4 months. Secondary outcomes consisted of FEV1 device usage during 4 months after receiving the FEV1 device. RESULTS A total of 39 participants (26 patients and 13 HCPs) were included in this study. Survey response rates were 97% (38/39) at the start and 87% (34/39) at the end of the study. Both patients and HCPs were receptive toward online FEV1 home monitoring and found it contributive to asthma control, self-management, and disease perception. The main concerns were about reliability of the FEV1 device and validity of home-performed lung function maneuvers. FEV1 devices were used with a median frequency of 7.5 (IQR 3.3-25.5) during the 4-month study period. CONCLUSIONS Patients and HCPs are receptive toward online FEV1 home monitoring. Frequency of measurements varied largely among individuals, yet perceived benefits remained similar. This emphasizes that online FEV1 home monitoring strategies should be used as a means to reach individual goals, rather than being a goal on their own.